| 2D | (two-dimensional) |
| 3D | (three-dimensional) |
| ADAMs | (disintegrin and metalloproteinases) |
| ADAMTS | (thrombospondin motifs) |
| ASKVKV | (Ala-Ser-Lys-Val-Lys-Val) |
| BFGF | (fibroblast growth factor) |
| BM | (basement membranes) |
| BMP | (bone morphogenetic protein) |
| CXCL | (C-X-C motif ligand) |
| CAC | (colitis-associated colon cancer) |
| CAFs | (cancer-associated fibroblasts) |
| COMP | (cartilage oligomeric matrix protein) |
| COX-2 | (cyclooxygenase 2) |
| CRC | (colorectal cancer) |
| CRLM | (colorectal liver metastasis) |
| DAMPs | (damage-associated molecular patterns) |
| DDR | (DNA damage response) |
| DDrs | (discoidin domain receptors) |
| dECM | (decellularized ECM) |
| DEFA3 | (Defensin Alpha 3) |
| EAC | (esophageal adenocarcinoma) |
| EBP | (elastin binding protein) |
| ECM | (extracellular matrix) |
| ED-A and ED-B | (extra domain A-B) |
| EGF | (epidermal growth factor) |
| EHS | (Engelbreth-Holm-Swarm) c |
| EMT | (epithelial to mesenchymal transition) |
| EP | (E-type prostanoid) |
| ERK | (extracellular-regulated kinase) |
| FAK | (focal adhesion kinase) |
| FGF-2 | (fibroblast growth factor) |
| FMLP | (formyl met-leu-phe) |
| FOLFIRI | (folinic acid, fluorouracil acid and irinotecan) |
| FOLFIRINOX | (folinic acid, fluoruracil acid, irinotecan and oxaliplatin) |
| GAGs | (glycosaminoglycans) |
| GLUT | (glucose transporters) |
| GM-CSF | (Granulocyte-Macrophage Colony-Stimulating Factor) |
| HA | (hyaluronic acid) |
| HIF | (hypoxia-inducible factor) |
| HC | (Healhty colon) |
| HL | (Healthy Liver) |
| IBD | (inflammatory bowel disease) |
| IFNγ | (interferon gamma) |
| ILs | (interleukins) |
| IM | (interstitial matrix) |
| IME | (inflammatory microenvironment) |
| JNK | (c-Jun N-terminal kinase) |
| LAP | (latency-associated protein) |
| LTBP | (Latent TGFβ binding protein) |
| LAP | (latency-associated protein) |
| LOX | (lysyl oxidases) |
| LOXLs | (LOX-like proteins) |
| MAPK | (mitogen-activated protein kinase) |
| MCs | (mast cells) |
| MT1-MMP | (membrane-type 1 matrix metalloproteinase) |
| MHs | (microporous hydrogels) |
| MIP | (macrophage inflammatory protein) |
| MMPs | (metalloproteinases) |
| MHC | (Major Histocompatibility Complex) |
| MTT | (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) |
| MYC | (myelocytomatosis) |
| NETs | (neutrophil extracellular traps) |
| NF-kB | (nuclear factor kappa-light-chain-enhancer of activated B cells) |
| NK | (natural killer) |
| OPN | (Osteopontin) |
| PAI | (plasminogen activator inhibitor) |
| PAMPs | (pathogen-associated patterns) |
| PDAC | (pancreatic ductal adenocarcinoma) |
| PDGF | (platelet-derived growth factor) |
| PDGF-EC | (platelet derived endothelial cell growth factor) |
| PGP | (Pro-Gly-Pro) |
| PGs | (proteoglycans) |
| PPARs | (peroxisome proliferator-activated receptors) |
| PGE2 | (Prostaglandin E2) |
| PTEN | (Phosphatase and tensin homolog) |
| PTPs | (protein tyrosine phosphatases) |
| PVDF | (polyvinylidene fluoride) |
| RA | (rheumatoid arthritis) |
| RNI | (reactive nitrogen intermediate) |
| RNS | (reactive nitrogen species) |
| ROCK1 | (Rho-associated protein kinase 1) |
| ROS | (reactive oxygen species) |
| SDF | (stromal cell-derived factor 1) |
| SERPINE2 | (serine proteinase inhibitor-E2) |
| SIKVAV | (Ser-Ile-Lys-Val-Ala-Val) |
| SRC | (Proto-oncogene tyrosine-protein kinase) |
| TAMs | (Tumor associated macrophages) |
| TANs | (tumor-associated neutrophils) |
| TGF-β | (transforming growth factor β) |
| Th17 | (T-helper IL-17 producing cells) |
| TINKs | (tumor-infiltrating natural killer cells) |
| TIMP | (tissue inhibitor of metalloproteinases) |
| TLRs | (Toll-like receptors) |
| TME | (tumor microenvironment) |
| TNF-α | (tumor necrosis factor α) |
| TNFR | (tumor necrosis factor receptor superfamily) |
| Tregs | (Regulatory T cells) |
| TSPs | (Thrombospondins) |
| VEGF | (vascular endothelial growth factors) |